The Freeman Lab is excited to announce a new cross-campus grant awarded by the Eshelman Institute for Innovation to pursue research in lung fibrosis. Dr. Ronit Freeman and Dr. Jim Hagood of the UNC School of Medicine will receive $350,000 towards their interdisciplinary research into peptide-based fibrosis therapeutics. This exciting novel drug technology will have the potential to not only ameliorate symptoms and slow disease progression, but to even reverse the damage to lung tissue caused by fibrosis.

You can read more about this exciting research at the UNC Health site here. To read the full announcement, visit the Eschelman Institute for Innovation’s website here.